John Wu

642 total citations
26 papers, 295 citations indexed

About

John Wu is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, John Wu has authored 26 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in John Wu's work include Orthopedic Surgery and Rehabilitation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Elbow and Forearm Trauma Treatment (4 papers). John Wu is often cited by papers focused on Orthopedic Surgery and Rehabilitation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Elbow and Forearm Trauma Treatment (4 papers). John Wu collaborates with scholars based in United States, China and Australia. John Wu's co-authors include Tarek Meniawy, Bo Gao, Linda Mileshkin, Michael Friedländer, Ben Markman, Joanne Lundy, Michael Millward, Virginia Paton, Alison Freimund and Paul R. Harnett and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

John Wu

25 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wu United States 10 139 111 62 40 38 26 295
Jebrane Bouaoud France 12 94 0.7× 116 1.0× 95 1.5× 23 0.6× 17 0.4× 45 358
Dongsheng Cao China 12 50 0.4× 118 1.1× 76 1.2× 17 0.4× 19 0.5× 31 310
Mostafa Mehrabi Bahar Iran 13 84 0.6× 154 1.4× 71 1.1× 27 0.7× 14 0.4× 28 326
Jeffrey D. Pollard United States 6 54 0.4× 168 1.5× 73 1.2× 18 0.5× 45 1.2× 8 324
Birgit Heinig Germany 15 145 1.0× 230 2.1× 21 0.3× 19 0.5× 60 1.6× 45 452
Toshio Takada Japan 10 38 0.3× 137 1.2× 100 1.6× 49 1.2× 71 1.9× 16 399
Rafik Mansouri France 6 62 0.4× 74 0.7× 85 1.4× 23 0.6× 35 0.9× 7 289
Carla Patrícia Martinelli-Kläy Switzerland 8 114 0.8× 42 0.4× 86 1.4× 27 0.7× 22 0.6× 17 275
Mahtab Rahbar Iran 10 47 0.3× 102 0.9× 138 2.2× 24 0.6× 34 0.9× 42 346
Flavia Persechino Italy 11 90 0.6× 38 0.3× 56 0.9× 20 0.5× 68 1.8× 42 300

Countries citing papers authored by John Wu

Since Specialization
Citations

This map shows the geographic impact of John Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wu more than expected).

Fields of papers citing papers by John Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wu. The network helps show where John Wu may publish in the future.

Co-authorship network of co-authors of John Wu

This figure shows the co-authorship network connecting the top 25 collaborators of John Wu. A scholar is included among the top collaborators of John Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wu. John Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hsu, Jason E., et al.. (2023). Dynamics of Cutibacterium repopulation onto the skin surface of the shoulder after chlorhexidine application. International Orthopaedics. 47(6). 1511–1515. 6 indexed citations
3.
Friedländer, Michael, Linda Mileshkin, Janine Lombard, et al.. (2023). Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial. British Journal of Cancer. 129(5). 797–810. 9 indexed citations
4.
5.
Desai, Jayesh, Peter C.C. Fong, Víctor Moreno, et al.. (2023). A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone and in combination with the PD-1 inhibitor, tislelizumab, in patients with advanced solid tumours. British Journal of Cancer. 128(8). 1418–1428. 10 indexed citations
6.
Edeline, Julien, Philippe Merle, Weijia Fang, et al.. (2022). Clinical outcomes associated with tislelizumab in patients (pts) with advanced hepatocellular carcinoma (HCC) who have been previously treated with sorafenib (SOR) or lenvatinib (LEN) in RATIONALE-208.. Journal of Clinical Oncology. 40(4_suppl). 420–420. 6 indexed citations
7.
Wu, John, et al.. (2021). Ulcerative cutaneous sarcoidosis successfully treated with infliximab. Clinical Rheumatology. 40(10). 4349–4354. 3 indexed citations
8.
9.
Chen, Huijing, Xinan Sheng, Beibei Hu, et al.. (2020). Recombinant humanized anti-PD-1 monoclonal antibody toripalimab in patients with refractory/metastatic urothelial carcinoma: Preliminary results of an open-label phase II clinical study. European Urology Open Science. 19. e1579–e1579. 1 indexed citations
10.
11.
Friedländer, Michael, Tarek Meniawy, Ben Markman, et al.. (2019). Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial. The Lancet Oncology. 20(9). 1306–1315. 89 indexed citations
12.
Wu, John & James H. Calandruccio. (2019). Evaluation and Management of Scaphoid-Trapezium-Trapezoid Joint Arthritis. Orthopedic Clinics of North America. 50(4). 497–508. 9 indexed citations
13.
Wu, John, et al.. (2019). Arthritis of the Thumb Interphalangeal and Finger Distal Interphalangeal Joint. Orthopedic Clinics of North America. 50(4). 489–496. 12 indexed citations
14.
Wu, John, et al.. (2019). Fracture Fixation Using Shape-Memory (Ninitol) Staples. Orthopedic Clinics of North America. 50(3). 367–374. 24 indexed citations
15.
Desai, Jayesh, B. Markman, Michael Friedländer, et al.. (2019). Abstract CT084: Long-term exposure (LTE) to Tislelizumab, an investigational anti-PD-1 antibody, in a first-in-human Phase I study. Cancer Research. 79(13_Supplement). CT084–CT084. 2 indexed citations
16.
Wu, John, et al.. (2019). Wrist Fractures and Osteoporosis. Orthopedic Clinics of North America. 50(2). 211–221. 20 indexed citations
17.
Wu, John, et al.. (2019). Operating Room Intervention Rates After Orthopaedic Resident-reduced Pediatric Both-Bone Forearm Fractures Relative to the Academic Calendar. Journal of Pediatric Orthopaedics. 40(5). 228–234. 1 indexed citations
18.
Wu, John, et al.. (2018). Posttraumatic Bifid Ulna in a Pediatric Galeazzi-Equivalent Forearm Fracture. The Journal Of Hand Surgery. 44(9). 802.e1–802.e8. 1 indexed citations
19.
Wu, John, et al.. (2016). Video Recording With a GoPro in Hand and Upper Extremity Surgery. The Journal Of Hand Surgery. 41(10). e383–e387. 20 indexed citations
20.
Navid, Fariba, Raymond Barfield, Rupert Handgretinger, et al.. (2011). A novel anti-GD2 monoclonal antibody (mAb), hu14.18K322A, in children with refractory or recurrent neuroblastoma: Early-phase evaluation.. Journal of Clinical Oncology. 29(15_suppl). 9523–9523. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jebrane Bouaoud Breakdown of academic impact, for papers by Dongsheng Cao Breakdown of academic impact, for papers by Mostafa Mehrabi Bahar Breakdown of academic impact, for papers by Jeffrey D. Pollard Breakdown of academic impact, for papers by Birgit Heinig Breakdown of academic impact, for papers by Toshio Takada Breakdown of academic impact, for papers by Rafik Mansouri Breakdown of academic impact, for papers by Carla Patrícia Martinelli-Kläy Breakdown of academic impact, for papers by Mahtab Rahbar Breakdown of academic impact, for papers by Flavia Persechino
Rankless by CCL
2026